Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aviad Tsherniak

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Molecular Cancer Research : MCR|November 20, 2015
Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted TherapyHugh S Gannon, Nathan Kaplan, Aviad Tsherniak, et al.
Nature Communications|May 24, 2017
Complementary information derived from CRISPR Cas9 mediated gene deletion and suppressionJoseph Rosenbluh, Han Xu, William Harrington, et al.
Nature Communications|January 5, 2021
Global computational alignment of tumor and cell line transcriptional profilesAllison Warren, Yejia Chen, Andrew Jones, et al.
Cold Spring Harbor Symposia on Quantitative Biology|November 6, 2016
Functional Genomic Characterization of Cancer GenomesThomas P Howard, Francisca Vazquez, Aviad Tsherniak, et al.
Genome Biology|December 21, 2021
Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effectsJoshua M Dempster, Isabella Boyle, Francisca Vazquez, et al.
Oncotarget|September 5, 2015
Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcomaAlyssa L Kennedy, Mounica Vallurupalli, Liying Chen, et al.
Cell Systems|January 27, 2022
Sparse dictionary learning recovers pleiotropy from human cell fitness screensJoshua Pan, Jason J Kwon, Jessica A Talamas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic featuresPablo Tamayo, Yoon-Jae Cho, Aviad Tsherniak, et al.
Cell Stem Cell|October 7, 2017
Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid NeoplasiaZuzana Tothova, John M Krill-Burger, Katerina D Popova, et al.
Cell Stem Cell|September 25, 2024
Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid NeoplasiaZuzana Tothova, John M Krill-Burger, Katerina D Popova, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Molecular Cancer Research : MCR|November 20, 2015
Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted TherapyHugh S Gannon, Nathan Kaplan, Aviad Tsherniak, et al.
Nature Communications|May 24, 2017
Complementary information derived from CRISPR Cas9 mediated gene deletion and suppressionJoseph Rosenbluh, Han Xu, William Harrington, et al.
Nature Communications|January 5, 2021
Global computational alignment of tumor and cell line transcriptional profilesAllison Warren, Yejia Chen, Andrew Jones, et al.
Cold Spring Harbor Symposia on Quantitative Biology|November 6, 2016
Functional Genomic Characterization of Cancer GenomesThomas P Howard, Francisca Vazquez, Aviad Tsherniak, et al.
Genome Biology|December 21, 2021
Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effectsJoshua M Dempster, Isabella Boyle, Francisca Vazquez, et al.
Oncotarget|September 5, 2015
Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcomaAlyssa L Kennedy, Mounica Vallurupalli, Liying Chen, et al.
Cell Systems|January 27, 2022
Sparse dictionary learning recovers pleiotropy from human cell fitness screensJoshua Pan, Jason J Kwon, Jessica A Talamas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic featuresPablo Tamayo, Yoon-Jae Cho, Aviad Tsherniak, et al.
Cell Stem Cell|October 7, 2017
Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid NeoplasiaZuzana Tothova, John M Krill-Burger, Katerina D Popova, et al.
Cell Stem Cell|September 25, 2024
Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid NeoplasiaZuzana Tothova, John M Krill-Burger, Katerina D Popova, et al.
Pageof 7